Investigating the Effects of Equine-Assisted Therapy in Individuals With Schizophrenia: A Randomized Controlled Trial.

Investigating the Effects of Equine-Assisted Therapy in Individuals With Schizophrenia: A Randomized Controlled Trial explored whether equine-assisted therapy could improve symptoms, reduce anxiety and loneliness, and enhance the quality of life in individuals with schizophrenia.

Study Objective

• To assess the effectiveness of equine-assisted therapy on reducing schizophrenia symptoms, anxiety, and loneliness, and on improving quality of life in affected individuals.

Study Design and Participants

• A randomized controlled trial was conducted involving 61 individuals diagnosed with schizophrenia.
• Participants were registered at a community mental health center.
• They were randomly divided into two groups: 30 in the intervention group (received equine-assisted therapy) and 31 in the control group (no such intervention).
• The intervention lasted for 8 weeks, during which the intervention group participated in equine-assisted therapeutic activities.

Data Collection Methods

• Personal Information Form to collect demographic and baseline data.
• Positive and Negative Syndrome Scale (PANSS) to assess the severity of schizophrenia symptoms.
• Trait Anxiety Inventory (TAI) to measure participants’ anxiety levels.
• Quality of Life Scale for Schizophrenia Patients (QLS) to evaluate their overall quality of life.
• UCLA Loneliness Scale (UCLA-LS) to measure levels of loneliness.

Data Analysis

• Descriptive statistics such as means, frequencies, and percentage distributions were calculated.
• Inferential statistics including chi-square tests, dependent samples t-tests, and independent samples t-tests were used to compare data within and between groups pre- and post-intervention.

Key Findings

• In the intervention group, statistically significant improvements were observed after therapy in:
  • Reduction of positive and negative symptoms as measured by PANSS.
  • Decreased anxiety levels according to TAI scores.
  • Lower loneliness scores on the UCLA Loneliness Scale.
  • Enhanced quality of life as measured by QLS.
• No significant changes were found in the control group across these measures, indicating the improvements were likely due to the equine-assisted therapy.

Conclusions

• Equine-assisted therapy appears to be an effective complementary treatment for individuals with schizophrenia.
• This therapy can alleviate core symptoms of schizophrenia, reduce anxiety and feelings of loneliness, and improve overall quality of life.
• The findings suggest that incorporating equine-assisted therapy in mental health treatment plans could provide valuable benefits to this population.